Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 171.03 USD -2.68%
Market Cap: 25.1B USD

Wall Street
Price Targets

BIIB Price Targets Summary
Biogen Inc

Wall Street analysts forecast BIIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIIB is 181.47 USD with a low forecast of 131.3 USD and a high forecast of 273 USD.

Lowest
Price Target
131.3 USD
23% Downside
Average
Price Target
181.47 USD
6% Upside
Highest
Price Target
273 USD
60% Upside
Biogen Inc Competitors:
Price Targets
TGTX
TG Therapeutics Inc
45% Upside
PTCT
PTC Therapeutics Inc
9% Upside
KURN
Kuros Biosciences AG
24% Upside
688235
Beigene Ltd
39% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
35% Upside
ORY
Oryzon Genomics SA
143% Upside
FHTX
Foghorn Therapeutics Inc.
173% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
13% Upside

Revenue
Forecast

Revenue Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

5%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

2%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

2%
Past Growth
11%
Estimated Growth
Estimates Accuracy
19%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIIB's stock price target?
Price Target
181.47 USD

According to Wall Street analysts, the average 1-year price target for BIIB is 181.47 USD with a low forecast of 131.3 USD and a high forecast of 273 USD.

What is Biogen Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

What is Biogen Inc's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

What is Biogen Inc's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

Back to Top